## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.9% below STRENGTH zone (3.0-6.0%); PEG 2.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($449.52)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 8)

**1. Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost**
- Source: GlobeNewswire | 20251222T180907 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds Synopsys, Inc. (NASDAQ: SNPS) investors of the December 30, 2025, deadline to file as lead plaintiff in a class action lawsuit. This suit alleges that the company made misleading statements between December 4, 2024, and September 9, 2025, concerning its Design IP business, which underperformed expectations and led to a significant stock price drop. Investors who suffered losses are urged to contact the firm to pursue claims for recovery under federal securities laws.

**2. Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit**
- Source: GlobeNewswire | 20251222T180031 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is alerting investors of Synopsys, Inc. (SNPS) to a December 30, 2025 deadline to file as lead plaintiff in a class action lawsuit. This lawsuit alleges that Synopsys made misleading statements regarding its business, operations, and prospects, leading to a significant stock price drop after the company reported disappointing Q3 2025 financial results and a decline in its Design IP segment. Investors who suffered losses between December 4, 2024, and September 9, 2025, are encouraged to contact the firm.

**3. SNPS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**
- Source: GlobeNewswire | 20251222T170849 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business, operations, and prospects, specifically concerning its Design IP business's deteriorating economics due to an increased focus on AI customers. Investors with substantial losses have until December 30, 2025, to request to be appointed as lead plaintiff.

**4. SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Synopsys, Inc. (NASDAQ: SNPS)**
- Source: GlobeNewswire | 20251222T131742 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has filed a securities class action lawsuit on behalf of investors who purchased Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misrepresentations regarding the deteriorating economics of its Design IP business due to an increased focus on artificial intelligence customers. Investors who wish to serve as lead plaintiff must file papers by December 30, 2025.

**5. Riverbridge Partners LLC Takes $26.68 Million Position in Synopsys, Inc. $SNPS**
- Source: MarketBeat | 20251222T122756 | Bullish | Relevance: 100%
- Riverbridge Partners LLC significantly increased its stake in Synopsys, Inc. (NASDAQ: SNPS) by acquiring 54,081 shares valued at approximately $26.68 million in the third quarter of 2025. This move comes amidst strong institutional ownership of Synopsys, impressive Q4/2025 earnings beats, positive FY2026 EPS guidance, and a "Moderate Buy" consensus from analysts. However, the company faces potential litigation exposure due to recently filed securities-fraud class-action notices, which could introduce volatility for the stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 4 ($0.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.88 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.7B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.88 |
| Forward P/E | 28.4 |
| Current P/E | 33.4 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.9% to 2.9% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.1pp (needs >3.0% for momentum thesis). MRS_5 at 2.3% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (1.73), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.85% (CS: 89) | Neutral |
| RSI_14 | 65.0 | Neutral |
| MACD Histogram | 1.73 | Bullish |
| vs SMA20 | 1.066x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 0.985x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $481.24
- **Stop Loss:** $449.52 (6.6% risk)
- **Target:** $512.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 37
- **Position Value:** $17,805.88
- **Portfolio %:** 17.81%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*